retatrutide study results 🚨The first phase 3 trial, TRIUMPH-4, top-line data announced today 🚨 Retatrutide - Wikipedia

In rare cases patients can experience severe side effects including gastroparesis, acute kidney injury and potentially pancreatitis

The profound impact on weight management and metabolic health has positioned these drugs as game-changers in the treatment landscape for obesity and type 2 diabetes

Holst, The expanding incretin universe: from basic biology to clinical translation

Retatrutide is an investigational injectable medicine from Eli Lilly

Better long-term results from weight loss are also speeding up the segment's growth

And posts from patients about the companys GLP-1 drugs which were advertised during the NBA Finals raise red flags